Nucleic Acid Sequencing and Genotyping Service
Nucleic Acid Sequencing and Genotyping Service - DNA sequencing; Microbes / Meta Genome; Human / An
Tender Timeline
Tender Title: Nucleic Acid Sequencing and Genotyping Service
Tender Reference Number: 19e185ffc
Issuing Authority/Department: Directorate General of Health Services, Ministry of Health and Family Welfare
Scope of Work and Objectives
The purpose of this tender is to procure Nucleic Acid Sequencing and Genotyping Services. The services will encompass DNA sequencing for various applications, including Microbes, Meta Genome, Human, and Animal Tissue analysis. The objective is to provide high-throughput sequencing capabilities to facilitate comprehensive genomic studies that will propel advancements in health-related research and diagnostics.
Eligibility Criteria
Eligible bidders must be registered entities with proven experience in nucleic acid sequencing and genotyping services. The service provider should demonstrate capability in handling both microbial and human/animal tissue samples while adhering to industry standards and benchmarks relevant to high-throughput sequencing.
Technical Requirements
Service providers must possess the following technical capabilities:
- High-throughput DNA sequencing technology with a minimum yield of 95% efficiency.
- Proficiency in collecting and processing samples from buyers, including nucleic acids (DNA or RNA).
- Ability to deliver raw data with a resolution of at least 100x.
Financial Requirements
Bidders are required to provide comprehensive financial documentation, which includes prior service contracts and evidence of financial stability. The proposal should reflect competitive pricing while meeting all specified technical requirements.
Document Submission Details
All required documents must be submitted electronically as part of the bidding process. This includes technical proposals, financial documentation, and any certificates relevant to the eligibility requirements. Submission methods will be clearly outlined in the tendering portal.
Special Provisions
There are special provisions in place to encourage participation from Micro, Small, and Medium Enterprises (MSEs) and startups, promoting inclusive growth and innovation within the sector. Bidders that qualify under these categories will receive priority consideration during the evaluation process.
Evaluation Process
The evaluation will be based on a comprehensive assessment of the submitted proposals, focusing on adherence to technical specifications, financial viability, and the previous experience of the bidders. The evaluation criteria are structured to ensure fairness and transparency in selecting the most suitable provider.
Delivery Locations
The services are to be delivered as specified by the buyer. All nucleic acid samples will be collected by the service provider from designated locations established in the preliminary agreement with the Directorate General of Health Services.
Contact Information
For any inquiries and further information regarding this tender, interested parties are encouraged to connect directly with the tender management team through the designated communication channels available on the tender portal.
This tender invites proposals from qualified vendors who are prepared to engage in a transformative project aimed at advancing the capabilities of nucleic acid research and analysis within the healthcare system. As this field evolves, participation from innovative service providers will be critical in achieving enhanced health outcomes through precision medicine and genomic research.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
5 DocumentsDocuments Required from Seller
- Experience Criteria
- Bidder Turnover
- Certificate (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements for participation in the Nucleic Acid Sequencing and Genotyping Services tender include being a legally registered entity with documented prior experience in providing similar services. Participants must demonstrate capability in both microbial and human/animal tissue sample handling, adhering to industry standards for DNA sequencing.
Bidders must present relevant certificates that certify their capabilities in high-throughput DNA sequencing and genotyping. This includes certificates of registration, quality management certifications, and any relevant documentation that supports their technical expertise in nucleic acid analysis.
To engage in the registration process, potential bidders must visit the tendering portal where they will create an account. After registration, they will have access to the tender documents, eligibility criteria, and submission guidelines to complete their proposals correctly.
The tender outlines several technical specifications that each bidder must meet. These include high-throughput DNA sequencing capabilities yielding 95% efficiency, capabilities in collecting and processing nucleic acid samples, and delivering raw data with at least 100x resolution. Compliance with these specifications is critical for evaluation.
Bidders should prepare for the Earnest Money Deposit (EMD) requirements as specified in the tender documents, which typically involves submitting a financial guarantee to secure their bid. Payment terms will be clarified upon awarding the contract, ensuring prompt compensation contingent on fulfilling the contracted services and meeting quality standards.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders